200 related articles for article (PubMed ID: 36704829)
1. Inflammatory cytokine-enriched microenvironment plays key roles in the development of breast cancers.
Takeuchi Y; Gotoh N
Cancer Sci; 2023 May; 114(5):1792-1799. PubMed ID: 36704829
[TBL] [Abstract][Full Text] [Related]
2. The membrane-linked adaptor FRS2β fashions a cytokine-rich inflammatory microenvironment that promotes breast cancer carcinogenesis.
Takeuchi Y; Kimura N; Murayama T; Machida Y; Iejima D; Nishimura T; Terashima M; Wang Y; Li M; Sakamoto R; Yamamoto M; Itano N; Inoue Y; Ito M; Yoshida N; Inoue JI; Akashi K; Saya H; Fujita K; Kuroda M; Kitabayashi I; Voon D; Suzuki T; Tojo A; Gotoh N
Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34663724
[TBL] [Abstract][Full Text] [Related]
3. Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.
Barham W; Chen L; Tikhomirov O; Onishko H; Gleaves L; Stricker TP; Blackwell TS; Yull FE
BMC Cancer; 2015 Sep; 15():647. PubMed ID: 26424146
[TBL] [Abstract][Full Text] [Related]
4. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
[TBL] [Abstract][Full Text] [Related]
5. Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination.
Zachariah NN; Basu A; Gautam N; Ramamoorthi G; Kodumudi KN; Kumar NB; Loftus L; Czerniecki BJ
Front Immunol; 2021; 12():786286. PubMed ID: 34899753
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli.
Piasecka D; Braun M; Mieszkowska M; Kowalczyk L; Kopczynski J; Kordek R; Sadej R; Romanska HM
Neoplasia; 2020 Nov; 22(11):576-589. PubMed ID: 32980776
[TBL] [Abstract][Full Text] [Related]
7. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
[TBL] [Abstract][Full Text] [Related]
8. β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.
Nam JM; Ahmed KM; Costes S; Zhang H; Onodera Y; Olshen AB; Hatanaka KC; Kinoshita R; Ishikawa M; Sabe H; Shirato H; Park CC
Breast Cancer Res; 2013; 15(4):R60. PubMed ID: 23883667
[TBL] [Abstract][Full Text] [Related]
9. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
11. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
[TBL] [Abstract][Full Text] [Related]
13. The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer.
Bennett L; Mallon EA; Horgan PG; Paul A; McMillan DC; Edwards J
Oncotarget; 2017 May; 8(20):33002-33013. PubMed ID: 28423692
[TBL] [Abstract][Full Text] [Related]
14. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
Doebar SC; van den Broek EC; Koppert LB; Jager A; Baaijens MHA; Obdeijn IAM; van Deurzen CHM
Breast Cancer Res Treat; 2016 Jul; 158(1):179-187. PubMed ID: 27318854
[TBL] [Abstract][Full Text] [Related]
15. NF-kappa B genes have a major role in inflammatory breast cancer.
Lerebours F; Vacher S; Andrieu C; Espie M; Marty M; Lidereau R; Bieche I
BMC Cancer; 2008 Feb; 8():41. PubMed ID: 18248671
[TBL] [Abstract][Full Text] [Related]
16. Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.
Visser LL; Elshof LE; Van de Vijver K; Groen EJ; Almekinders MM; Sanders J; Bierman C; Peters D; Hofland I; Broeks A; van Leeuwen FE; Rutgers EJT; Schmidt MK; Schaapveld M; Lips EH; Wesseling J
Am J Surg Pathol; 2019 Nov; 43(11):1574-1582. PubMed ID: 31206365
[TBL] [Abstract][Full Text] [Related]
17. Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.
Bergholtz H; Kumar S; Wärnberg F; Lüders T; Kristensen V; Sørlie T
Cancer Rep (Hoboken); 2020 Jun; 3(3):e1248. PubMed ID: 32671987
[TBL] [Abstract][Full Text] [Related]
18. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.
Erez N; Glanz S; Raz Y; Avivi C; Barshack I
Biochem Biophys Res Commun; 2013 Aug; 437(3):397-402. PubMed ID: 23831470
[TBL] [Abstract][Full Text] [Related]
19. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
[TBL] [Abstract][Full Text] [Related]
20. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
